Bulum Burcu, Özçakar Z Birsin, Kavaz Aslı, Tutar Ercan, Ekim Mesiha, Yalçınkaya Fatoş
Department of Pediatric Nephrology, Ankara University School of Medicine, Ankara, Turkey.
Department of Pediatric Cardiology, Ankara University School of Medicine, Ankara, Turkey.
Pediatr Int. 2015 Dec;57(6):1138-42. doi: 10.1111/ped.12703. Epub 2015 Nov 5.
Hypertension (HT) is a common and serious complication following renal transplantation in children, and an important risk factor for cardiovascular morbidity and mortality. This study evaluated the clinical characteristics of HT in children after renal transplantation.
Twenty-four children who were followed up at least 6 months after renal transplantation were enrolled in the study. From the clinical records, demographic and laboratory data, casual blood pressure (BP) measurement, ambulatory BP monitoring (ABPM), medication, and left ventricular mass index (LVMI) at echocardiogram were documented.
Mean age at time of transplantation was 12.6 ± 3.0 years and mean follow-up period was 19.6 ± 15.8 months. HT was detected in 21 children (87.5%) after renal transplantation. Twelve patients (50%) had HT both before and after transplantation and nine (38%) had HT only after transplantation. HT developed in 67% within the first week and in 95% within the first month. All hypertensive children had night-time HT and no child had isolated daytime HT. The efficacy of HT control was 42%. Median LVMI in patients with HT after renal transplantation was 42.3 g/m(2.7).
Severe HT, an important complication, was frequently seen in the early period after renal transplantation. Predominance of nocturnal HT and the lack of isolated daytime HT after transplantation underline the importance of ABPM. ABPM should be performed regularly in the first year after transplantation, not only for diagnosis but also for evaluation of HT control.
高血压(HT)是儿童肾移植后常见且严重的并发症,也是心血管发病和死亡的重要危险因素。本研究评估了儿童肾移植后HT的临床特征。
本研究纳入了24例肾移植后至少随访6个月的儿童。从临床记录中记录人口统计学和实验室数据、偶测血压(BP)测量、动态血压监测(ABPM)、用药情况以及超声心动图检查时的左心室质量指数(LVMI)。
移植时的平均年龄为12.6±3.0岁,平均随访期为19.6±15.8个月。21例(87.5%)儿童肾移植后检测出HT。12例患者(50%)移植前后均有HT,9例(38%)仅移植后出现HT。67%在第一周内发生HT,95%在第一个月内发生。所有高血压儿童均有夜间HT,无儿童仅表现为日间HT。HT控制有效率为42%。肾移植后HT患者的LVMI中位数为42.3 g/m(2.7)。
严重HT作为一种重要并发症,在肾移植后早期较为常见。夜间HT占优势以及移植后缺乏孤立的日间HT突出了ABPM的重要性。移植后第一年应定期进行ABPM,不仅用于诊断,还用于评估HT控制情况。